Skip to content

Insider · CIK 0001989644

William Hartzel

officer

Files at EBS (Emergent BioSolutions Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 11, 2025EBS
Emergent BioSolutions Inc.
FTax withholding
Common Stock
-610$10.88$6,637103,082Nov 13, 2025
Jul 11, 2025EBS
Emergent BioSolutions Inc.
FTax withholding
Common Stock
-4,263$7.36$31k103,692Jul 15, 2025
Jun 8, 2025EBS
Emergent BioSolutions Inc.
FTax withholding
Common Stock
-1,167$6.63$7,737107,955Jun 10, 2025
Apr 7, 2025EBS
Emergent BioSolutions Inc.
FTax withholding
Common Stock
-561$4.44$2,491109,122Apr 9, 2025
Mar 6, 2025EBS
Emergent BioSolutions Inc.
AGrant or award
Common Stock
+62,500$0.00$0109,683Apr 9, 2025
Mar 6, 2025EBS
Emergent BioSolutions Inc.
AGrant or award
Common Stock
+62,500$0.00$0109,975Mar 10, 2025
Mar 6, 2025EBS
Emergent BioSolutions Inc.
AGrant or award
Employee Stock Options (Right to Buy)derivative
+62,500$0.00$0214,711Mar 10, 2025
Mar 5, 2025EBS
Emergent BioSolutions Inc.
FTax withholding
Common Stock
-292$5.80$1,69447,183Mar 7, 2025
Nov 11, 2024EBS
Emergent BioSolutions Inc.
FTax withholding
Common Stock
-632$11.97$7,56547,475Nov 13, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

William Hartzel: insider trades and track record | InsiderTell